Concepedia

Author

Silvia Svegliati

Marche Polytechnic UniversityORCID

Also Known As

S Svegliati, S Svegliati Baroni, S. Svegliati, S. Svegliati Baroni, S. Svegliati-Baroni, S. svegliati, Silvia Svegliati, Silvia Svegliati Baroni

69

Publications

2.8K

Citations

28

H-Index

68

Concepts

All Affiliations

Marche Polytechnic UniversityOspedali Riuniti di AnconaUniversity of Naples Federico IIUniversity of TurinAzienda Ospedaliero Universitaria Ospedali Riuniti
SS

About

Silvia Svegliati is an author at Marche Polytechnic University specializing in medicine, immunology, and oxidative stress.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

433

2

Allergy

3

3

61

3

Health Sciences

2

2

33

4

Natural Sciences

1

1

46

5

Biochemistry

1

1

46

Silvia Svegliati

×

32

Publications

2.4K

Citations

22

H-Index

YearCitations

Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis

Silvia Svegliati, Mariarosaria Santillo, Federica Bevilacqua,

New England Journal of Medicine

2006

571

Oxidative stress in scleroderma: Maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway

Paola Sambo, Silvia Svegliati, Michele Maria Luchetti,

Arthritis & Rheumatism

2001

228

Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease

Silvia Svegliati, Attilio Olivieri, Nadia Campelli,

Blood

2007

215

Platelet-derived Growth Factor and Reactive Oxygen Species (ROS) Regulate Ras Protein Levels in Primary Human Fibroblasts via ERK1/2

Silvia Svegliati, Raffaella Cancello, Paola Sambo,

Journal of Biological Chemistry

2005

174

Reactive Oxygen Species Are Required for Maintenance and Differentiation of Primary Lung Fibroblasts in Idiopathic Pulmonary Fibrosis

Marialuisa Bocchino, Savina Agnese, Evelina Fagone,

PLoS ONE

2010

145

Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients

Jacopo Sabbatinelli, Angelica Giuliani, Giulia Matacchione,

Mechanisms of Ageing and Development

2020

112

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD

Attilio Olivieri, Michele Cimminiello, Paolo Corradini,

Blood

2013

98

Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis

Silvia Svegliati, Giusi Marrone, Antonio Pezone,

Science Signaling

2014

96

Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement

Vania Patrone, Edoardo Puglisi, Marco Cardinali,

Scientific Reports

2017

92

A Reactive Oxygen Species–Mediated Loop Maintains Increased Expression of NADPH Oxidases 2 and 4 in Skin Fibroblasts From Patients With Systemic Sclerosis

Tatiana Spadoni, Silvia Svegliati, Donatella Amico,

Arthritis & Rheumatology

2015

60

Page 1